检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘芳[1] 马道新[1] 谭炳煦[1] 高晖[1] 王建波[1] 张萍[1] 郭颖[1] 程玉峰[1]
机构地区:[1]山东大学齐鲁医院肿瘤防治研究中心,济南250012
出 处:《山东大学学报(医学版)》2009年第4期33-37,共5页Journal of Shandong University:Health Sciences
基 金:山东省卫生厅科技发展计划资助项目(2006GG3202008)
摘 要:目的构建真核表达质粒pIRES-Rb94,观察Rb94基因对鞘氨醇激酶(SphK)表达的影响。方法根据Rb94基因序列设计、合成引物,构建以内部核糖体进入位点(IRES)相连的Rb94基因的真核表达质粒pIRES-Rb94,经脂质体转染A549细胞,G418筛选获得稳定转染的细胞株。采用Real-time RT-PCR和Western boltting法检测Rb94基因并观察其对人肺腺癌A549细胞株SphK表达的影响。结果成功构建重组表达质粒pIRES-Rb94,转染A549细胞后获得稳定转染细胞株pIRES-Rb94-A549,该细胞株中Rb94基因高效表达;SphK1表达下调而SphK2表达上调。结论真核表达质粒pIRES-Rb94构建成功并可有效转染A549细胞,Rb94基因抑制SphK1的表达,增强SphK2的表达。Objective To construct a eukaryofic expression plasmid pIRES-Rb94 and investigate its effect on expression of SphK in lung adenocarcinoma A549 cell line. Methods A primer of Rb94 was designed and composed based on the Rb94 sequence. The Rb94 gene was cloned by PCR and was sequenced. The eukaryofie expression plasmid plRKS-Rb94 was correctly constructed and transfected into the A549 cells by lipofectamine 2000, then the stably transfeeted pIRES-Rb94 cell line was selected through CA18. Expression of the Rb94 gene was detected by real time RT-PCR and Western blotting. Results The recombination ex- pression vector containing the Rb94 gene was successfully constructed and a new cell hne with stable and high expression of Rb94 was established. Real time RT-PCR and Western Blotting analysis demonstrated that the Rb94 gene could be effectively expressed in the A549 cells. Moreover, expression of SphK1 was down-regulated and of SphK2 was up-regulated. Conclusion The plRES-Rb94 expression plasmid was successfully constructed and could be effectively transfected into A549 cells. After transfec- tion, Rb94 can efficiendy inhibit expression of SphK1, and enhances expression of SphK2 in the A549 cell line.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.189.11.177